Cyclopentylamine → N-Cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-8-amine

HRID 1295880Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1295880
Cl[C:2]1[C:3]2[N:4]([C:8]([C:19]3[CH:24]=[CH:23][N:22]=[C:21]([NH:25][C:26]4[CH:31]=[CH:30][CH:29]=[CH:28]C=4)[N:20]=3)=[C:9]([C:11]3[CH:16]=[CH:15][CH:14]=[C:13]([O:17][CH3:18])[CH:12]=3)[N:10]=2)[CH:5]=[CH:6][CH:7]=1.C1(P(C2C=CC=CC=2)C2C=CC3C(=CC=CC=3)C=2C2C3C(=CC=CC=3)C=CC=2P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C(=O)([O-])[O-].[Cs+].[Cs+].C(OCC)(=O)C.[CH:90]1([NH2:95])[CH2:94][CH2:93][CH2:92][CH2:91]1>C([O-])(=O)C.[Pd+2].C([O-])(=O)C.O>[CH:90]1([NH:95][C:2]2[C:3]3[N:4]([C:8]([C:19]4[CH:24]=[CH:23][N:22]=[C:21]([NH:25][CH:26]5[CH2:31][CH2:30][CH2:29][CH2:28]5)[N:20]=4)=[C:9]([C:11]4[CH:16]=[CH:15][CH:14]=[C:13]([O:17][CH3:18])[CH:12]=4)[N:10]=3)[CH:5]=[CH:6][CH:7]=2)[CH2:94][CH2:93][CH2:92][CH2:91]1

Komponenten

8

Edukt 5

HCID 2906CyclopentylamineHCID 8857Ethyl AcetateHCID 10796Cesium carbonateHCID 634876Binap, (A+-)-HCID 102741414-[8-chloro-2-(3-methoxyphenyl)imidazo[1,2-alpha]pyridin-3-yl]-N-phenylpyrimidin-2-amine

Produkt 1

HCID 10139996N-Cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-8-amineAusbeute 31 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 167845palladium(II) acetateKatalysatorHCID 962WaterLösungsmittel

Reaktionsbedingungen

Temperatur
150 °C

Versuchsvorschrift

To a solution of 4-[8-chloro-2-(3-methoxyphenyl)imidazo[1,2-α]pyridin-3-yl]-N-phenylpyrimidin-2-amine (162 mg, 0.39 mmol) in cyclopentylamine (5 mL) was added, successively, racemic-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (15.3 mg, 0.02 mmol), cesium carbonate (376 mg, 1.15 mmol) and palladium (II) acetate (3.5 mg, 0.015 mmol). The resulting mixture was heated in a sealed tube at 150° C. for 24 hours at which time the reaction was judged complete by thin layer chromatography. The solution was cooled to room temperature and ethyl acetate and water were added. The phases were separated and the organic layer was washed with water and brine. The combined organics were dried over magnesium sulfate, filtered and concentrated. The residue was purified by flash chromatography (2:1 hexanes-ethyl acetate) to give N-cyclopentyl-3-[2-(cyclopentylamino)-4-pyrimidinyl]-2-(3-methoxyphenyl)imidazo[1,2-α]pyridin-8-amine (55 mg, 31%) as a white solid. 1H NMR (CDCl3): δ 8.90 (m, 1 H), 8.08 (d, 1 H), 7.37–7.22 (m, 2 H), 6.96 (m, 1 H), 6.79 (t, 1 H), 6.43 (d, 1 H), 6.30 (d, 1 H), 5.40 (d, 1 H), 5.31 (d, 1 H), 4.37 (m, 1 H), 3.94 (m, 1 H), 3.85 (s, 3 H), 2.14–2.07 (m, 4 H), 1.82–1.56 (m, 12 H); MS m/z 469 (M+1).

Aufarbeitung

  1. temperatureThe solution was cooled to room temperature
  2. customThe phases were separated
  3. washthe organic layer was washed with water and brine
  4. dry with materialThe combined organics were dried over magnesium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customThe residue was purified by flash chromatography (2:1 hexanes-ethyl acetate)

Quellen und Nachweise

ORD-Eintrag
ord-d2654a3790124d02b27fa39e681c6f20
Quelldatensatz
uspto-grants-2007_07
Patentnummer
US07244740B2

Notizen zur Reaktion

Wird geladen…